Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions; solid tumor molecular profiling for somatic cancer testing; rapid whole genome testing for children in NICU and PICU; newborn genetic analysis panel; single front-line test to detect ataxia-related variants and repeat expansions through sequencing; picture genetics, a patient-initiated genetic testing; whole exome and clinical exome panel tests; whole genome, mutation, and repeat expansion testing services, as well as research service tests. It also provides next generation sequencing and reverse transcription polymerase chain reaction-based tests, as well as antigen-based diagnostic tests for the detection of SARS-CoV-2. In addition, the company offers flow cytometry, a cell analysis technique providing diagnosis, prognosis, and monitoring of malignancies; fluorescence in-situ hybridization for detecting and locating a specific DNA sequence on a chromosome; immunohistochemistry, an imaging technique used to visualize antigens in cells; cytogenetics, which analyzes the chromosome set for numerical and structural abnormalities; and molecular testing that includes hematopoietic and solid tumor molecular assays. The company serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. Fulgent Genetics has strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Over the last 12 months, insiders at Fulgent Genetics, Inc. have bought $0 and sold $1.38M worth of Fulgent Genetics, Inc. stock.
On average, over the past 5 years, insiders at Fulgent Genetics, Inc. have bought $0 and sold $7.21M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,478 shares for transaction amount of $43,240 was made by Hsieh Ming (President and CEO) on 2019‑03‑05.
2023-12-11 | Sale | Xie Jian | President and COO | 22,000 0.0746% | $26.52 | $583,453 | -15.98% | |
2023-12-04 | Sale | Gao Hanlin | Chief Scientific Officer | 1,437 0.0049% | $27.57 | $39,623 | -18.42% | |
2023-12-04 | Sale | Xie Jian | President and COO | 1,779 0.006% | $27.57 | $49,053 | -18.42% | |
2023-12-04 | Sale | Kim Paul | CFO and Treasurer | 1,437 0.0049% | $27.57 | $39,623 | -18.42% | |
2023-11-16 | Sale | Xie Jian | President and COO | 1,617 0.0054% | $27.25 | $44,065 | -16.12% | |
2023-11-16 | Sale | Kim Paul | CFO and Treasurer | 1,307 0.0043% | $27.25 | $35,617 | -16.12% | |
2023-09-07 | Sale | Gao Hanlin | Chief Scientific Officer | 1,041 0.0035% | $31.41 | $32,696 | -21.29% | |
2023-09-07 | Sale | Xie Jian | President and COO | 1,492 0.005% | $31.41 | $46,861 | -21.29% | |
2023-09-07 | Sale | Kim Paul | CFO and Treasurer | 1,492 0.005% | $31.41 | $46,861 | -21.29% | |
2023-08-28 | Sale | Kim Paul | CFO and Treasurer | 10,299 0.0344% | $33.62 | $346,297 | -25.21% | |
2023-08-17 | Sale | Gao Hanlin | Chief Scientific Officer | 342 0.0011% | $33.88 | $11,587 | -26.30% | |
2023-08-17 | Sale | Xie Jian | President and COO | 1,307 0.0043% | $33.88 | $44,283 | -26.30% | |
2023-08-17 | Sale | Kim Paul | CFO and Treasurer | 1,798 0.0059% | $33.88 | $60,918 | -26.30% | |
2023-06-02 | Sale | Gao Hanlin | Chief Scientific Officer | 1,000 0.0034% | $40.30 | $40,296 | -34.04% | |
2023-06-02 | Sale | Xie Jian | President and COO | 1,433 0.0048% | $40.30 | $57,744 | -34.04% | |
2023-06-02 | Sale | Kim Paul | CFO and Treasurer | 1,403 0.0047% | $40.30 | $56,535 | -34.04% | |
2023-05-17 | Sale | Gao Hanlin | Chief Scientific Officer | 345 0.0012% | $35.46 | $12,234 | -24.10% | |
2023-05-17 | Sale | Xie Jian | President and COO | 1,320 0.0044% | $35.46 | $46,810 | -24.10% | |
2023-05-17 | Sale | Kim Paul | CFO and Treasurer | 1,266 0.0043% | $35.46 | $44,895 | -24.10% | |
2022-12-02 | Sale | KIM PAUL | CFO and Treasurer | 653 0.0022% | $35.33 | $23,070 | -12.04% |
Gao Hanlin | Chief Scientific Officer | 905882 3.057% | $20.36 | 0 | 14 | |
Xie Jian | President and COO | 363124 1.2254% | $20.36 | 0 | 34 | |
Kim Paul | CFO and Treasurer | 200460 0.6765% | $20.36 | 0 | 45 | |
Hsieh Ming | President and CEO | 6579326 22.2026% | $20.36 | 18 | 1 | +22.28% |
BOLGER JOHN C | 3500 0.0118% | $20.36 | 0 | 9 |
BlackRock | $85.08M | 13.1 | 3.92M | +4.22% | +$3.44M | <0.01 | |
The Vanguard Group | $30.91M | 4.76 | 1.42M | +0.58% | +$179,176.91 | <0.01 | |
Dimensional Fund Advisors | $29.19M | 4.5 | 1.35M | -7.06% | -$2.22M | 0.01 | |
State Street | $17.89M | 2.76 | 824,477 | +1.42% | +$250,526.50 | <0.01 | |
Park West Asset Management Llc | $15.84M | 2.44 | 729,783 | +71.8% | +$6.62M | 1.19 | |
Millennium Management LLC | $15.49M | 2.39 | 713,871 | +95.73% | +$7.58M | 0.01 | |
Geode Capital Management | $10.25M | 1.58 | 472,381 | +2.08% | +$208,804.36 | <0.01 | |
Ameriprise Financial | $7.81M | 1.2 | 360,135 | +43.7% | +$2.38M | <0.01 | |
Divisadero Street Capital Management Lp | $7.49M | 1.15 | 345,000 | +151.25% | +$4.51M | 1.76 | |
Charles Schwab | $6.4M | 0.99 | 294,940 | +10.34% | +$599,505.90 | <0.01 | |
Nuveen | $5.34M | 0.82 | 246,050 | -10.79% | -$645,726.90 | <0.01 | |
Northern Trust | $4.8M | 0.74 | 221,028 | -4.48% | -$224,985.62 | <0.01 | |
Morgan Stanley | $4.78M | 0.74 | 220,248 | -16.35% | -$933,925.07 | <0.0001 | |
Invesco | $3.7M | 0.57 | 170,539 | -53.84% | -$4.32M | <0.01 | |
Bank of America | $3.64M | 0.56 | 167,590 | +61.59% | +$1.39M | <0.0001 | |
Bridgeway Capital Management | $3.51M | 0.54 | 161,875 | +5.35% | +$178,482.52 | 0.07 | |
JPMorgan Chase | $3.44M | 0.53 | 158,628 | -52.7% | -$3.84M | <0.0001 | |
Barclays | $3.28M | 0.51 | 151,141 | +205.13% | +$2.21M | <0.01 | |
BNY Mellon | $3.17M | 0.49 | 146,181 | -6.25% | -$211,531.42 | <0.01 | |
D. E. Shaw & Co. | $2.93M | 0.45 | 134,928 | +231.56% | +$2.04M | <0.01 | |
TCW Group | $2.53M | 0.39 | 116,600 | 0% | +$0 | 0.03 | |
Citadel Advisors LLC | $2.44M | 0.38 | 112,439 | -8.5% | -$226,569.67 | <0.01 | |
Empowered Funds Llc | $2.37M | 0.37 | 109,167 | +8.15% | +$178,482.51 | 0.04 | |
Deutsche Bank | $2.05M | 0.32 | 94,271 | +34.72% | +$527,179.62 | <0.01 | |
Mirae Asset Global Investments Co Ltd | $2.59M | 0.29 | 86,792 | +98.18% | +$1.29M | <0.01 | |
Goldman Sachs | $1.82M | 0.28 | 83,770 | -18.2% | -$404,531.62 | <0.0001 | |
Point72 Asset Management | $1.78M | 0.27 | 81,800 | -45.94% | -$1.51M | <0.01 | |
HSBC | $1.64M | 0.25 | 75,751 | +374.96% | +$1.3M | <0.01 | |
RhumbLine Advisers | $1.47M | 0.23 | 67,573 | +1.54% | +$22,285.61 | <0.01 | |
Susquehanna International Group | $1.47M | 0.23 | 67,686 | +356.66% | +$1.15M | <0.01 | |
Jane Street Capital | $1.37M | 0.21 | 63,150 | -53.5% | -$1.58M | <0.01 | |
Algert Global LLC | $1.21M | 0.19 | 55,760 | New | +$1.21M | 0.05 | |
Legal & General | $1.17M | 0.18 | 54,074 | -46.09% | -$1M | <0.0001 | |
Cubist Systematic Strategies | $1.11M | 0.17 | 50,940 | +1,408.44% | +$1.03M | 0.01 | |
Renaissance Technologies | $987,000.00 | 0.15 | 45,500 | -3.81% | -$39,046.15 | <0.01 | |
Exchange Traded Concepts, LLC | $979,321.00 | 0.15 | 45,130 | +21.74% | +$174,880.30 | 0.02 | |
Public Sector Pension Investment Board | $907,407.00 | 0.14 | 41,816 | 0% | +$0 | 0.01 | |
Russell Investments Group Ltd | $862,921.00 | 0.13 | 39,766 | -18.97% | -$201,983.32 | <0.01 | |
Advisory Services Network Llc | $857,150.00 | 0.13 | 39,500 | -2.65% | -$23,370.90 | 0.02 | |
Swiss National Bank | $833,280.00 | 0.13 | 38,400 | 0% | +$0 | <0.01 | |
Federated Hermes | $816,072.00 | 0.13 | 37,607 | +11.02% | +$80,984.41 | <0.01 | |
First Trust | $785,323.00 | 0.12 | 36,190 | +9.26% | +$66,553.90 | <0.01 | |
Trexquant Investment LP | $754,726.00 | 0.12 | 34,780 | New | +$754,726.00 | 0.01 | |
Jump Financial Llc | $698,762.00 | 0.11 | 32,201 | New | +$698,762.00 | 0.01 | |
American Century Investments | $683,355.00 | 0.11 | 31,491 | -10.38% | -$79,118.24 | <0.0001 | |
Credit Suisse | $677,235.00 | 0.1 | 31,209 | +2.85% | +$18,770.49 | <0.01 | |
UBS | $588,721.00 | 0.09 | 27,130 | -12.11% | -$81,092.90 | <0.0001 | |
Prudential Financial | $504,243.00 | 0.08 | 23,237 | +0.09% | +$434.00 | <0.01 | |
Ubs Asset Management Americas Inc | $509,279.00 | 0.08 | 23,469 | +16.27% | +$71,284.74 | <0.0001 | |
Petrus Trust Company Lta | $471,997.00 | 0.07 | 21,751 | -11.04% | -$58,590.04 | 0.04 |